News
Perplexity now offers live BSE & NSE stock prices in India, plus market analysis. But does it also give investment advice?
Q2 2025 Earnings Call Transcript August 13, 2025 Euroseas Ltd. beats earnings expectations. Reported EPS is $4.29, ...
Q2 2025 Earnings Call Transcript August 13, 2025 Operator: Good afternoon, everyone, and thank you for participating on today’s second quarter 2025 earnings Conference Call and Webcast for Barfresh ...
Operator: Greetings, and welcome to Forian Inc. Second Quarter 2025 Financial Results Conference Call and webcast.
Operator: Thank you for standing by, and welcome to Motorsport Games, Inc.’s Second Quarter 2025 Earnings Call. [Operator Instructions] As a reminder, today’s conference is being recorded. I would now ...
Advancing novel programs for respiratory viruses that pose pandemic threats or risk of serious illness, including SARS CoV2 (ratutrelvir) and influenza (Tivoxavir marboxil, TXM) Prioritization of ratu ...
and saying the labor market remained solid. Meanwhile, President Trump said he was down to three or four candidates to replace Fed Chair Jerome Powell and said he was likely to make a nomination "a ...
New Delhi, Rural India continued to outpace the urban market in the June quarter with 8.4 per cent volume growth, compared to a 4.6 per cent increase in urban areas, according to the latest report ...
Expion360 Inc. (NASDAQ: XPON) Q2 2025 Earnings Call Transcript August 13, 2025 Expion360 Inc. beats earnings expectations. Reported EPS is $-0.41, expectations were $-0.58.
53m
Investor's Business Daily on MSNDow Jones Futures: Is Stock Market Rotating? This Cathie Wood, Nancy Pelosi Pick Is A Buy
Dow Jones futures edged higher early Thursday, along with S&P 500 futures and Nasdaq futures, with more economic data ahead. Cisco SystemsCSCO headlined earnings late Wednesday.The stock market rally ...
Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage medical technology company dedicated to transforming care for fluid overload patients, today announced financial results for the second quarter ended ...
Following positive preclinical data, simufilam development to advance with a clinical study expected to begin in H1 2026 for the potential treatment of TSC-related epilepsyRecent appointment of experi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results